PCRX | Pacira BioSciences, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	13.04 - 13.90
52 Week Range	11.16 - 35.95
Beta	-233.47
Implied Volatility	85.59%
IV Rank	0.25%
Day's Volume	1,919,296
Average Volume	1,397,151
Shares Outstanding	46,126,900
Market Cap	622,251,881
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2011-02-03

Valuation
Profitability
Growth
Health
P/E Ratio	10.07
Forward P/E Ratio	N/A
EPS	1.34
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	711
Country	USA
Website	PCRX

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

PCRX's peers: ALKS, AMPH, ANIP, ASRT, COLL, DVAX, ELAN, EOLS, ESPR, EVO, HCM, INCR, IRWD, ITCI, KMDA, LNTH, NBIX, PAHC, PBH, RDY, SSIC, IXHL, EGRX, DCPH, PETQ, PRGO, SCYX, SIGA, SUPN, TAK, TBIO, ALVO

*Chart delayed

Analyzing fundamentals for PCRX we got that it has average fundamentals where Valuation is considered to be significantly undervalued, Profitability is unacceptably poor, Growth is on medium level and Health is passable. For more detailed analysis please see PCRX Fundamentals page.

Watching at PCRX technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on PCRX Technicals page.